Company Deep Dive
Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.
BB1.AX
SellBlinkLab Limited · Healthcare · Australia · $86M · Avg Vol: $151K/d
COMPANY DESCRIPTION
BlinkLab Limited develops smartphone-based diagnostic tests for neurological and psychiatric disorders, including autism and ADHD, using AI-driven auditory testing. The company leverages proprietary machine learning algorithms and patented digital biomarkers to deliver low-cost, accessible, and early-stage neurodevelopmental screenings. It is an innovative digital health company disrupting traditional, high-cost clinical diagnostic pathways.
FINANCIAL SUMMARY (AUD)
| Year | 2023 | 2024 | 2025 | CAGR | TTM | 2027E | 2028E | Fwd CAGR |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | 7.9M | 57.9M | — |
| EPS (AUD) | -0.01 | -0.02 | -0.06 | — | -0.06 | -0.05 | -0.05 | — |
| Shares | 99.2M | 99.2M | 124.3M | +25.4% | 153.3M | — | — | — |
| Debt | 15.2K | 0.2M | 0.1M | 191.0% | 0.4M | — | — | — |
| Equity | 40.7K | 6.5M | 9.0M | 1384.2% | — | — | — | — |
| Op CF | -0.5M | -1.8M | -4.2M | — | -6.3M | — | — | — |
| Inv CF | -83.1K | -3.1M | 2.9M | — | — | — | — | — |
| Fin CF | -14.2K | 7.9M | 7.0M | — | — | — | — | — |
SCORE BREAKDOWN
FUNDAMENTALS
SECTOR PEERS
Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of BB1.AX are excluded.
| Ticker | Company | Mkt Cap | StockRank | Signal |
|---|---|---|---|---|
| BB1.AX | BlinkLab Limited(you) | $86M | 21 | Sell |
| PHX.AX | PharmX Technologies Limited | $59M | 22 | Sell |
| PKY.AX | Pathkey.AI Ltd | $57M | 21 | Sell |
| ALC.AX | Alcidion Group Limited | $93M | 54 | Hold |
| EIQ.AX | Echo IQ Limited | $740M | 28 | Sell |
| AYA.AX | Artrya Limited | $557M | 35 | Hold |
| CGS.AX | Cogstate Limited | $380M | 92 | Strong Buy |
| ILA.AX | Island Pharmaceuticals Limited | $93M | 19 | Strong Sell |
| ATH.AX | Alterity Therapeutics Limited | $81M | 28 | Sell |
| ACW.AX | Actinogen Medical Limited | $118M | 18 | Strong Sell |
Peer medians: ROE -20.6% · P/E 34.6x · Gross margin 62.6%